Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 04/23/26
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q1 EarningsZacks Investment Research • 04/23/26
Biotech Investor Alex Karnal: GLP-1 Drugs Signal ‘Trillion-Dollar Revolution' in Public Health24/7 Wall Street • 04/22/26
Obesity Drugs Covered In Medicare Change. Questions Remain For Lilly, Novo.Investors Business Daily • 04/22/26
Eli Lilly (LLY) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 04/21/26
Eli Lilly's Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analystsProactive Investors • 04/21/26
Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50Market Watch • 04/21/26
Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, OthersInvestors Business Daily • 04/20/26
Eli Lilly expands genetic medicine capabilities with Kelonia Therapeutics acquisitionProactive Investors • 04/20/26
Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation?The Motley Fool • 04/20/26
Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ saysReuters • 04/19/26